GLP-1, Cholesterol and Your Heart: What the SELECT Trial Means for Indians

For years, weight loss medicines were judged on one number: kilograms. That era ended in 2023 when the SELECT trial, following over 17,000 people with obesity and existing heart disease for years, showed semaglutide reduced heart attacks, strokes and cardiovascular death by 20%. Notably, the protection began appearing before most of the weight had come off, suggesting the medicine helps the cardiovascular system through more than the scale alone. For Indians, who carry among the world's highest premature heart disease rates, this reframes what GLP-1 treatment is actually for.

The Indian heart problem, briefly

• Heart disease strikes Indians roughly 10 years earlier on average than Western populations, with a large share of heart attacks occurring before age 50.
• The classic Indian lipid pattern is not sky-high LDL; it is high triglycerides, low HDL and small dense LDL particles, driven substantially by visceral fat and insulin resistance.
• This is why cholesterol trouble in India so often arrives at normal-looking body weights: the thin-fat phenotype hides the driver around the waist.

What GLP-1 medicines do to your lipid panel

Through weight loss, and particularly visceral fat loss, GLP-1 treatment typically lowers triglycerides meaningfully, nudges LDL down modestly, raises HDL slightly, and reduces the liver fat that manufactures the harmful lipid pattern in the first place. It also drops systolic blood pressure by several points on average and lowers inflammatory markers like CRP. None of this replaces a statin where one is indicated; the two attack different parts of the problem and are routinely prescribed together.

Who benefits most

1. 1People with existing heart disease and excess weight, the SELECT population itself, where the 20% event reduction applies most directly.
2. 2People with the Indian metabolic cluster: borderline sugar, high triglycerides, low HDL, waist above 90 cm (men) or 80 cm (women), fatty liver on ultrasound.
3. 3People with strong family history of early heart attacks, where getting visceral fat down in your 30s and 40s is the highest-leverage prevention available.

Track the right numbers

Weigh-ins are motivating, but the heart story lives in a different dashboard: waist circumference, blood pressure, fasting triglycerides, HDL, HbA1c and, where measured, liver enzymes. A good program tests these before treatment and at intervals during it, so in month six you are not just lighter; you can see the risk numbers moving. That is the report that changes what your 60s look like.